Frank Greenway | The Robert Scott Bell Show

Health Concerns

Obese patients lose weight on new Orexigen drug

August 5, 2010 RSB Staff antidepressant, Arena Pharmaceuticals Inc, Arne Astrup, combination treatment, Contrave, Frank Greenway, GlaxoSmithKline, Lancet medical journal, lose weight, naltrexone, Obese patients, obesity studies, Orexigen drug, The Food and Drug Administration, U.S. companies, U.S. researchers, United States, weight loss, Wellbutrin

Overweight volunteers who took Orexigen’s experimental drug Contrave, designed to reduce cravings, lost about 13 pounds (6 kg) over a

Copyright © 2023 The Robert Scott Bell Show. All rights reserved.
Theme: ColorMag by ThemeGrill. Powered by WordPress.